Clinical Trials on 复发性肝癌 in Hong Kong
总计1044个结果
-
The University of Hong KongMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany完全的
-
Chinese University of Hong Kong完全的
-
Humanity & Health Medical Group Limited招聘中
-
Humanity & Health Medical Group LimitedBeijing 302 Hospital; Kindai University Faculty of Medicine终止
-
Chinese University of Hong KongHealth and Medicine Research Fund招聘中
-
Chinese University of Hong KongThe Hong Kong Society of Gastroenterology完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完全的
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong Kong完全的
-
The University of Hong Kong未知
-
Aegera TherapeuticsChinese University of Hong Kong完全的
-
The University of Hong Kong招聘中复发性胶质母细胞瘤 | 复发性胶质瘤 | 聚 ADP 核糖聚合酶 (PARP) 抑制剂 | PTEN基因失活 | IDH突变香港
-
Chinese University of Hong Kong尚未招聘
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong Kong终止
-
Hospital Authority, Hong KongSchering-Plough未知
-
The University of Hong KongResearch Grant Council招聘中